Prism Medico And Pharmacy Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/08/2026 ,inter alia, to consider and approve Unaudited Standalone Financial Results of the company along with the Limited Review Report for the quarter ended 30th June, 2026, as per Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.
Prism Medico & Pharmacy Ltd. Press Release Aug 05 2026
Filed with BSE · · 1 page · English
Release
Prism Medico & Pharmacy Ltd. on 6ix
Earlier from Prism Medico & Pharmacy
- Prism Medico & Pharmacy Ltd. Press Release Jul 21 2026
- Prism Medico & Pharmacy Ltd. Press Release Jul 13 2026
- Prism Medico & Pharmacy Ltd. Press Release May 23 2026
- Prism Medico & Pharmacy Ltd. Press Release Apr 29 2026
- Prism Medico & Pharmacy Ltd. Press Release Apr 21 2026
Later from Prism Medico & Pharmacy
- Prism Medico & Pharmacy Ltd. Press Release Aug 12 2026
- Prism Medico & Pharmacy Ltd. Press Release Aug 19 2026
- Prism Medico & Pharmacy Ltd. Press Release Aug 26 2026
- Prism Medico & Pharmacy Ltd. Press Release Sep 19 2026
- Closure of Trading Window
Follow Prism Medico & Pharmacy into a list and get an email when it puts out news.
Follow Prism Medico & Pharmacy